A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection

NCT05784129 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped Janssen made an internal business decision to discontinue the PROGRESS study. This decision is not related to any efficacy or safety concerns.

Conditions

Interventions

Sponsor

Janssen Research & Development, LLC